Name: FDA approve donanemab treatment for early Alzhiemer disease
Start: 2025-02-02T12:30:00+03:00
End: 2025-02-02T13:30:00+03:00
Location: كلية الصيدلة

Monday, 27 January 2025
Tuesday, 28 January 2025
Wednesday, 29 January 2025
Thursday, 30 January 2025
Friday, 31 January 2025
Saturday, 1 February 2025
Sunday, 2 February 2025

12:30 FDA approve donanemab treatment for early Alzhiemer disease
FDA approve donanemab treatment for early Alzhiemer disease
12:30 - 13:30